Selected article for: "activation status and immune system"
Author: Bielka, Weronika; Przezak, Agnieszka; Pawlik, Andrzej
Title: Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection
  • Cord-id: 4gcfxnyf
  • Document date: 2021_7_16
    • ID: 4gcfxnyf
    Snippet: COVID-19 infection poses an important clinical therapeutic problem, especially in patients with coexistent diseases such as type 2 diabetes. Potential pathogenetic links between COVID-19 and diabetes include inflammation, effects on glucose homeostasis, haemoglobin deoxygenation, altered immune status and activation of the renin-angiotensin-aldosterone system (RAAS). Moreover, drugs often used in the clinical care of diabetes (dipeptidyl peptidase 4 inhibitors, glucagon-like peptide 1 receptor a
    Document: COVID-19 infection poses an important clinical therapeutic problem, especially in patients with coexistent diseases such as type 2 diabetes. Potential pathogenetic links between COVID-19 and diabetes include inflammation, effects on glucose homeostasis, haemoglobin deoxygenation, altered immune status and activation of the renin-angiotensin-aldosterone system (RAAS). Moreover, drugs often used in the clinical care of diabetes (dipeptidyl peptidase 4 inhibitors, glucagon-like peptide 1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, metformin and insulin) may influence the course of SARS-CoV-2 infection, so it is very important to verify their effectiveness and safety. This review summarises the new advances in diabetes therapy and COVID-19 and provides clinical recommendations that are essential for medical doctors and for patients suffering from type 2 diabetes.

    Search related documents:
    Co phrase search for related documents
    • aberrant glycosylation and activation platelet: 1, 2
    • academic hospital and acute ards respiratory distress syndrome: 1
    • academic hospital and acute disorder: 1
    • acid inducible and action mechanism: 1, 2
    • acid inducible gene and action mechanism: 1, 2
    • action mechanism and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • action mechanism and acute disorder: 1
    • activation platelet and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8